- Home
- SSP vs BIOA Comparison
SSP vs BIOA Comparison
Compare SSP & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- BIOA
- Stock Information
- Founded
- SSP 1878
- BIOA 2015
- Country
- SSP United States
- BIOA United States
- Employees
- SSP N/A
- BIOA N/A
- Industry
- SSP Broadcasting
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- SSP Industrials
- BIOA Health Care
- Exchange
- SSP Nasdaq
- BIOA Nasdaq
- Market Cap
- SSP 187.3M
- BIOA 144.1M
- IPO Year
- SSP 1988
- BIOA 2024
- Fundamental
- Price
- SSP $2.59
- BIOA $4.11
- Analyst Decision
- SSP Buy
- BIOA Hold
- Analyst Count
- SSP 2
- BIOA 4
- Target Price
- SSP $6.25
- BIOA $5.67
- AVG Volume (30 Days)
- SSP 772.5K
- BIOA 246.5K
- Earning Date
- SSP 05-08-2025
- BIOA 05-06-2025
- Dividend Yield
- SSP N/A
- BIOA N/A
- EPS Growth
- SSP N/A
- BIOA N/A
- EPS
- SSP 1.01
- BIOA N/A
- Revenue
- SSP $2,509,772,000.00
- BIOA $1,451,000.00
- Revenue This Year
- SSP N/A
- BIOA N/A
- Revenue Next Year
- SSP $9.18
- BIOA N/A
- P/E Ratio
- SSP $2.37
- BIOA N/A
- Revenue Growth
- SSP 9.46
- BIOA N/A
- 52 Week Low
- SSP $1.36
- BIOA $2.88
- 52 Week High
- SSP $4.65
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- SSP 58.30
- BIOA N/A
- Support Level
- SSP $2.25
- BIOA N/A
- Resistance Level
- SSP $2.48
- BIOA N/A
- Average True Range (ATR)
- SSP 0.19
- BIOA 0.00
- MACD
- SSP 0.05
- BIOA 0.00
- Stochastic Oscillator
- SSP 87.74
- BIOA 0.00
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.